Boston Scientific Lowers Forecast and Warns on 2027
Boston Scientific lowered its annual profit outlook and warned of a tough 2027. The company cited pricing pressure in China and weak demand for key heart devices. Shares dropped following the announcement.
Xurve View
Insights:
Xurve View

BOSTON SCIENTIFIC CORP cut its full-year profit outlook on Wednesday afternoon, warning that revenue growth will face severe headwinds in 2027. The medtech firm cited mounting pricing pressure in China and slowing momentum across key cardiac product lines.







